Skip to main content

Table 2 Patient outcomes

From: Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds

  Within 30 Days Between 31 Days and 1 year After 1 year
  All Diab No Diab P HR [95% CI] All Diab No Diab P HR [95% CI] All Diab No Diab p HR [95% CI]
All Death 12 (1.9%) 2 (1.5%) 10 (2.0%) 0.713 0.75 [0.19–3.02] 7 (1.2%) 1 (0.8%) 6 (1.3%) 0.666 0.63 [0.10–3.89] 24 (5.2%) 8 (7.7%) 16 (4.5%) 0.129 1.91 [0.71–5.11]
CV Death 7 (1.1%) 2 (1.5%) 5 (1.0%) 0.623 1.50 [0.24–9.26] 5 (0.8%) 0 5 (1.0%) 0.250 12 (2.5%) 7 (6.9%) 5 (1.4%) 0.001 5.37 [1.33–21.71]
Any MI 12 (1.9%) 4 (3.0%) 8 (1.6%) 0.286 1.90 [0.47–7.64] 16 (2.7%) 4 (3.3%) 12 (2.6%) 0.661 1.29 [0.38–4.32] 25 (5.5%) 6 (6.4%) 19 (5.3%) 0.705 1.19 [0.46–3.13]
Target Vessel MI 10 (1.6%) 3 (2.2%) 7 (1.4%) 0.477 1.62 [0.35–7.46] 12 (2.0%) 4 (3.3%) 8 (1.7%) 0.275 1.93 [0.48–7.81] 15 (2.8%) 3 (2.6%) 12 (2.8%) 0.928 0.94 [0.27–3.27]
ScR 13 (2.2%) 5 (4.0%) 8 (1.7%) 0.116 2.38 [0.62–9.09] 28 (10.3%) 13 (17.6%) 15 (7.8%) < 0.001 3.56 [1.40–9.05]
ScT 14 (2.2%) 3 (2.2%) 11 (2.2%) 0.963 1.03 [0.28–3.73] 5 (0.9%) 0 5 (1.1%) 0.251 9 (1.7%) 1 (1.4%) 8 (1.8%) 0.459 0.46 [0.09–2.30]
TLR 22 (3.7%) 6 (4.9%) 16 (3.4%) 0.443 1.44 [0.51–4.04] 33 (11.5%) 12 (17.0%) 21 (9.5%) 0.016 2.32 [0.98–5.47]
  1. P < 0.05 as statistically significant are in bold